70
Views
8
CrossRef citations to date
0
Altmetric
Review

Improving macrovascular outcomes in type 2 diabetes: outcome studies in cardiovascular risk and metabolic control

Pages S15-S26 | Accepted 30 Jun 2006, Published online: 14 Aug 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stanley Schwartz. (2008) Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide. Current Medical Research and Opinion 24:11, pages 3009-3022.
Read now
A. H. Barnett. (2006) Introduction: beyond glycemic control in type 2 diabetes. Current Medical Research and Opinion 22:sup2, pages S1-S4.
Read now

Articles from other publishers (6)

Karen A. Weikel, José M. Cacicedo, Neil B. Ruderman & Yasuo Ido. (2015) Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells. American Journal of Physiology-Cell Physiology 308:3, pages C249-C263.
Crossref
Ralph A. DeFronzo & Muhammad Abdul-Ghani. (2011) Assessment and Treatment of Cardiovascular Risk in Prediabetes: Impaired Glucose Tolerance and Impaired Fasting Glucose. The American Journal of Cardiology 108:3, pages 3B-24B.
Crossref
Juan Ybarra, Josep M. Pou, June Hart Romeo, Javier Merce & Jeroni Jurado. (2010) Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study. Journal of Diabetes and its Complications 24:5, pages 306-312.
Crossref
Alastair Matheson. (2008) Corporate Science and the Husbandry of Scientific and Medical Knowledge by the Pharmaceutical Industry. BioSocieties 3:4, pages 355-382.
Crossref
Antonio Ceriello. (2008) Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. Diabetes/Metabolism Research and Reviews 24:1, pages 14-26.
Crossref
John E. Gerich. (2007) Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors. Clinical Cornerstone 8:3, pages 53-68.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.